Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies

Head and Neck Oncology

Volumn 3, Issue 1, 2011, Pages

  Pederson, Aaron W ^a   Salama, Joseph K ^b   Haraf, Daniel J ^c   Witt, Mary Ellen ^c   Stenson, Kerstin M ^c   Portugal, Louis ^c   Seiwert, Tanguy ^c,d   Villaflor, Victoria M ^c,d   Cohen, Ezra E W ^c,d   Vokes, Everett E ^c,d   Blair, Elizabeth A ^c  

^a MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; GEMCITABINE; HYDROXYUREA; IRINOTECAN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ESOPHAGUS DILATATION; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MALE; MINOR SALIVA GLAND; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; OVERALL SURVIVAL; PAROTID GLAND CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SALIVARY GLAND CANCER; SUBMANDIBULAR GLAND; TEMPOROMANDIBULAR JOINT DISORDER; TREATMENT OUTCOME; TUBE FEEDING; XEROSTOMIA; ADJUVANT CHEMORADIOTHERAPY; MIDDLE AGED; PATHOLOGY; SALIVARY GLAND TUMOR; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; HUMANS; HYDROXYUREA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; SALIVARY GLAND NEOPLASMS; TREATMENT OUTCOME;

EID: 79960687676     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-3-31     Document Type: Article

References (29)

1. Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY, Arch Otolaryngol Head Neck Surg 1990 116 290 293 2306346 (Pubitemid 20100601)
2. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Laramore GE, Krall JM, Griffin TW, et al. Int J Radiat Oncol Biol Phys 1993 27 235 240 8407397 (Pubitemid 23304448)
3. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW, Int J Radiat Oncol Biol Phys 2007 67 138 143 10.1016/j.ijrobp.2006.07.1380 17049183 (Pubitemid 44959484)
4. Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy. Chen AM, Granchi PJ, Garcia J, Bucci MK, Fu KK, Eisele DW, Int J Radiat Oncol Biol Phys 2007 67 982 987 10.1016/j.ijrobp.2006.10.043 17241753
5. Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Fu KK, Leibel SA, Levine ML, Friedlander LM, Boles R, Phillips TL, Cancer 1977 40 2882 2890 10.1002/1097-0142(197712)40:6<2882::AID-CNCR2820400618>3.0.CO;2-I 201357
6. Postoperative radiation therapy for major salivary gland malignancies. Harrison LB, Armstrong JG, Spiro RH, Fass DE, Strong EW, J Surg Oncol 1990 45 52 55 10.1002/jso.2930450112 2166187 (Pubitemid 20283878)
7. Management of malignant tumors of the salivary glands. Spiro RH, Oncology (Williston Park) 1998 12 671 680 discussion 683 (Pubitemid 128617863)
8. Postoperative and primary radiotherapy for salivary gland carcinomas: indications, techniques, and results. Terhaard CH, Int J Radiat Oncol Biol Phys 2007 69 52 55 17848295
9. The role of radiotherapy in the treatment of malignant salivary gland tumors. Terhaard CH, Lubsen H, Rasch CR, et al. Int J Radiat Oncol Biol Phys 2005 61 103 111 10.1016/j.ijrobp.2004.03.018 15629600 (Pubitemid 40039111)
10. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Dreyfuss AI, Clark JR, Fallon BG, Posner MR, Norris CM Jr, Miller D, Cancer 1987 60 2869 2872 10.1002/1097-0142(19871215)60:12<2869::AID-CNCR2820601203>3.0.CO;2-Y 2824016 (Pubitemid 18005856)
11. Chemotherapy for salivary gland cancer. Kaplan MJ, Johns ME, Cantrell RW, Otolaryngol Head Neck Surg 1986 95 165 170 3035459 (Pubitemid 16025390)
12. Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients. Licitra L, Cavina R, Grandi C, et al. Ann Oncol 1996 7 640 642 8879381 (Pubitemid 26285647)
13. Herceptin plus chemotherapy in relapsed and/or metastatic salivary gland cancer. Locati LD, Rinaldi G, Bossi P, et al. Oral Oncol 2005 41 97 98 15598592 (Pubitemid 39647126)
14. Carcinoma of the minor salivary glands: results of surgery and combined therapy. Chou C, Zhu G, Luo M, Xue G, J Oral Maxillofac Surg 1996 54 448 453 10.1016/S0278-2391(96)90119-6 8600261 (Pubitemid 26105607)
15. Prognostic factors in major salivary gland cancer. Hocwald E, Korkmaz H, Yoo GH, et al. Laryngoscope 2001 111 1434 1439 10.1097/00005537-200108000-00021 11568581 (Pubitemid 32730192)
16. Triozzi PL, Brantley A, Fisher S, Cole TB, Crocker I, Huang AT, 5-Fluorouracil, cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck. Cancer 1987 59 887 890 10.1002/1097-0142(19870301)59: 5<887::AID-CNCR2820590505>3.0.CO;2-8 2434202 (Pubitemid 17024639)
17. Concurrent chemoradiotherapy with cyclophosphamide, pirarubicin, and cisplatin for patients with locally advanced salivary gland carcinoma. Katori H, Tsukuda M, Acta Otolaryngol 2006 126 1309 1314 10.1080/00016480600818070 17101593 (Pubitemid 44764331)
18. Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel. Maruya S, Namba A, Matsubara A, et al. Int J Clin Oncol 2006 11 403 406 10.1007/s10147-006-0587-0 17058139 (Pubitemid 44627663)
19. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure. Argiris A, Haraf DJ, Kies MS, Vokes EE, Oncologist 2003 8 350 360 10.1634/theoncologist.8-4-350 12897332 (Pubitemid 36929720)
20. Nonparametric estimation from incomplete observations. Kaplan ELMP, J Am Stat Assoc 1958 53 547 581
21. The chemoradiation paradigm in head and neck cancer. Seiwert TY, Salama JK, Vokes EE, Nat Clin Pract Oncol 2007 4 156 171 10.1038/ncponc0750 17327856 (Pubitemid 46358853)
22. Chemoradiotherapy for locally advanced head and neck cancer. Salama JK, Seiwert TY, Vokes EE, J Clin Oncol 2007 25 4118 4126 10.1200/JCO.2007.12.2697 17827462 (Pubitemid 47492956)
23. Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma. Airoldi M, Gabriele AM, Gabriele P, et al. Tumori 2001 87 14 17 11669550 (Pubitemid 32273844)
24. Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. Chen AM, Bucci MK, Quivey JM, Garcia J, Eisele DW, Fu KK, Int J Radiat Oncol Biol Phys 2006 66 1044 1050 10.1016/j.ijrobp.2006.06.050 16965870 (Pubitemid 44633522)
25. Role of Radiotherapy in the Treatment of Tumors of the Salivary Glands. Laramore GE, Salivary Gland Disorders Springer, Myers ENF, R L, 2007 463 475
26. Treatment of salivary gland neoplasms with fast neutron radiotherapy. Douglas JG, Koh WJ, Austin-Seymour M, Laramore GE, Arch Otolaryngol Head Neck Surg 2003 129 944 948 10.1001/archotol.129.9.944 12975266 (Pubitemid 37087654)
27. Salivary gland malignancies: the role for chemotherapy and molecular targeted agents. Surakanti SG, Agulnik M, Semin Oncol 2008 35 309 319 10.1053/j.seminoncol.2008.03.009 18544445 (Pubitemid 351787699)
28. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. Agulnik M, Cohen EW, Cohen RB, et al. J Clin Oncol 2007 25 3978 3984 10.1200/JCO.2007.11.8612 17761983 (Pubitemid 47477277)
29. Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study. Haddad R, Colevas AD, Krane JF, et al. Oral Oncol 2003 39 724 727 10.1016/S1368-8375(03)00097-6 12907212 (Pubitemid 36930120)